FOSUNPHARMA(SH:600196) Zheng Quan Zhi Xing·2025-03-26 10:34Group 1 - The company announced its first A-share repurchase plan, with a total repurchase amount expected to be between RMB 30 million and RMB 60 million [1][2] - The repurchase period is set from January 22, 2025, to July 21, 2025, and the maximum repurchase price is capped at RMB 30 per share [1] - The purpose of the repurchase includes employee stock ownership plans, equity incentives, and maintaining company value and shareholder rights [1] Group 2 - As of March 26, 2025, the company has repurchased a total of 812,800 A-shares, representing 0.0304% of the total share capital, with a total expenditure of approximately RMB 1,999.09 million [2] - The average repurchase price on that day was RMB 24.60 per share, with a price range between RMB 24.54 and RMB 24.66 [2] - The company will continue to repurchase shares based on market conditions and will fulfill its information disclosure obligations regarding the progress of the repurchase plan [2]